NCT06926530View on ClinicalTrials.gov

Herbs & Supplements in Breast Cancer Usage, Impact, and Personalized Approaches for Diverse Populations

Not yet recruitingOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Breast CancerBreast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIBreast Carcinoma
Interventions
OTHER

No intervention

Participants will complete a one-time 33-question survey. The survey is comprised of three sections: (1) Section A includes 12 questions related to demographic information, (2) Section B consists of 2 questions addressing treatment characteristics, \& (3) Section C contains 19 questions focusing on supplement usage.

Trial Locations (2)

33331

Cleveland Clinic Florida, Weston

44195

Cleveland Clinic Main Campus, Cleveland

All Listed Sponsors
lead

Case Comprehensive Cancer Center

OTHER